| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4827568 | B | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control | Homo sapiens | 32 | single protein format | Scientific Literature | ||
| 2. | ALA4827569 | B | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control | Homo sapiens | 32 | single protein format | Scientific Literature | ||
| 3. | ALA4827570 | B | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control | Homo sapiens | 32 | single protein format | Scientific Literature | ||
| 4. | ALA4827571 | B | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control | Homo sapiens | 22 | single protein format | Scientific Literature | ||
| 5. | ALA4827572 | B | Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 9 | assay format | Scientific Literature | ||
| 6. | ALA4827573 | B | Inhibition of wild-type human partial length CAMKK1 (R65 to E414 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 9 | assay format | Scientific Literature | ||
| 7. | ALA4827574 | B | Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 3 | assay format | Scientific Literature | ||
| 8. | ALA4827576 | B | Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 3 | assay format | Scientific Literature | ||
| 9. | ALA4827578 | B | Inhibition of wild-type human partial length CDK11 (M1 to N360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 3 | assay format | Scientific Literature | ||
| 10. | ALA4827582 | B | Inhibition of wild-type human partial length EPHB6 (Q634 to P948 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 3 | assay format | Scientific Literature | ||
| 11. | ALA4827584 | B | Inhibition of wild-type human full length CSNK2A2 (M1 to R350 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 12. | ALA4827585 | B | Inhibition of wild-type human full length CSNK2A1 (M1 to Q391 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 13. | ALA4827586 | B | Inhibition of wild-type human partial length PIK3CG (S144 to A1102 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 14. | ALA4827587 | B | Inhibition of wild-type human partial length NEK10 (L488 to R809 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 15. | ALA4827588 | B | Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 16. | ALA4827589 | B | Inhibition of wild-type human partial length ICK (M1 to P314 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 2 | assay format | Scientific Literature | ||
| 17. | ALA4827590 | B | Inhibition of wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 18. | ALA4827591 | B | Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 19. | ALA4827592 | B | Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 20. | ALA4827593 | B | Inhibition of wild-type human partial length CAMKK1 (R65 to E414 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!